HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
MOBI DEV (00947) spent HKD 2103 on November 12 to repurchase 15,000 shares.
12/11/2024
GMT Eight
MOBI DEV (00947) announcement that on November 12, 2024, it will spend 2103 Hong Kong dollars to repurchase 15,000 shares.
Fuan Pharmaceutical's subsidiary received the notification of approval for the sodium benzosulfonate chemical raw material drug market application.
BOSS ZHIPIN-W (02076) purchased a total of 342,600 shares of Class A common stock after the initial public offering.
RECOMMEND
Wall Street Consensus: The Federal Reserve will slow down interest rate cuts in 2025.
18 min ago
Be wary of the tariff war and declining demand! Goldman Sachs lowers its copper price target to $8,500.
16/11/2024
New share prospects | Four-pronged approach to meet the "Red Sea" competition, has Subao International shaken off growth anxiety?
16/11/2024
©️2013 - 2024 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com